Pfizer
Manufacturing · New York, United States · 88,000 Employees
View Company Info for Free
About
Headquarters
66 Hudson Boulevard East, New York City, New Yo...Phone Number
(212) 733-2323Website
www.pfizer.comRevenue
$54.9 BillionStock Symbol
PFEIndustry
Most Recent Scoops
Highlights
$1.3B
Total Funding Amount
$1.3B
Most Recent Funding Amount
1
Number of Funding Rounds
Who is Pfizer
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Viagra, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that will lose or have lost marketing patent protection; branded generic products; sterile injectable products; biosimilars; and infusion systems. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, and Pristiq brand names. This segment also engages in contract manufacturing business. The company has licensing agreements with Cellectis SA and AstraZeneca plc; and collaborative agreements with Eli Lilly & Company and Merck KGaA. It also has a research collaboration and license agreement with HitGen Ltd. to build and screen DNA-encoded libraries in order to discover small molecule leads to be used in drug development; collaboration with Merck and Corning for pharma glass packaging project; and an agreement with InSphero AG to develop a predictive toxicology assay using InSphero 3D InSight human liver microtissues for predicting drug induced liver injury. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. Pfizer Inc. was founded in 1849 and is headquartered in New York.Read more
Popular Searchespfizer IncPfizerPfizer LtdPfizer Canada IncPfizer CoSIC Code 28,283NAICS Code 32,325Ticker NYSE: PFEShow morePfizer Org Chart
Is Pfizer your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Click to see if Pfizer had a recent Job posting/layoffs
Earning: See what the market has to say on Pfizer recently announced quarterly report
Check if Pfizer has recently received funding, and reach out quickly before it becomes old news!
Check out if Pfizer is spiking on competitors!
Funding: Get notified immidiatlly once Pfizer has new funding data
Product Launch: Get notified when Pfizer launches new products
Pfizer, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Pfizer
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Pfizer
Find 3 more new buyers
Similar Companies to Pfizer
Analyze insights from companies similar to Pfizer and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- Merck & Co70,000$61.4B
- Novartis76,057$47.7B
- Eli Lilly43,000$35.9B
- GSK70,212$40B
- AstraZeneca89,900$49.1B
- Bristol-Myers Squibb34,100$45.5B
- Takeda47,347$26.9B
- AbbVie50,000$54.4B
More similar companies
Compare CEO
How does Albert Bourla compare against Competing Companies' CEOs?
Albert Bourla
CEO at Pfizer
CEO effectiveness to drive business results
VS.
Severin Schwan
CEO at Roche
CEO effectiveness to drive business results
Severin Schwan
CEO at Roche
Robert Ford
CEO at Abbott
Richard Gonzalez
CEO at AbbVie
Joaquin Duato
CEO at Johnson & Johnson Servi...
Rob Davis
CEO at Merck & Co
Pfizer Email Formats
Pfizer uses at least 5 email formats with first.last (ex. John.Smith@pfizer.com) being used 72.9% of the time
Pfizer Email Formats | Percentage | |
---|---|---|
first.last | John.Smith@pfizer.com | 72.9% |
first.last | John.Smith@hospira.com | 0.9% |
first + middle.last | JohnL.Smith@hospira.com | 0.1% |
first + last | JohnSmith@pfizer.com | |
first_last | John_Smith@pfizer.com |
Get Verified Emails
Pfizer financials insights
Gather financial insights about Pfizer, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Pfizer Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Pfizer Tech Stack
A closer look at the technologies used by Pfizer
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Most Recent Scoops
Pfizer News & Media
Intel, Pfizer, Trump Media and Target rise premarket; Apple falls
Investing.com -- U.S. stock futures edged largely higher Monday, with traders cautious ahead of the latest Federal Reserve policy-setting meeting.Pfizer Inc. Reveals Their Findings on New Cachexia Drug
Pfizer Inc. has just announced their results from a Phase 2 study of one of their new drugs, ponsegromab, which is a monoclonal antibody. It's role is targeting the growth differentiation factor-15 (GDF-15) in patients with cancer cachexia.Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation factor-15 (GDF-15), met its primary endpoint of change from baseline in body weight compared to placebo in people with cancer cachexia and elevated levels of GDF-15. Cachexia is a common, life-threatening wasting condition that can significantly impact quality of life in affected patients with cancer.ii,iii Results will be presented t
Frequently Asked Questions Regarding Pfizer
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including... Read More